ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 62 filers reported holding ACUMEN PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,864,345 | +35.5% | 1,895,023 | +57.1% | 0.05% | +50.0% |
| Q2 2023 | $5,803,496 | +18.5% | 1,206,548 | 0.0% | 0.03% | -3.0% |
| Q1 2023 | $4,898,585 | -24.8% | 1,206,548 | 0.0% | 0.03% | +10.0% |
| Q4 2022 | $6,515,359 | -46.2% | 1,206,548 | 0.0% | 0.03% | -57.7% |
| Q3 2022 | $12,101,000 | +113.4% | 1,206,548 | 0.0% | 0.07% | -19.3% |
| Q2 2022 | $5,671,000 | +120.8% | 1,206,548 | +83.7% | 0.09% | +183.9% |
| Q1 2022 | $2,568,000 | -42.2% | 656,848 | 0.0% | 0.03% | -31.1% |
| Q4 2021 | $4,440,000 | -54.5% | 656,848 | 0.0% | 0.04% | +9.8% |
| Q3 2021 | $9,761,000 | – | 656,848 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $18,452 | 5.05% |
| Knollwood Investment Advisory, LLC | 1,678,510 | $9,063,954 | 3.55% |
| GUARDIAN POINT CAPITAL, LP | 300,000 | $1,620,000 | 1.28% |
| GREAT POINT PARTNERS LLC | 1,116,581 | $6,029,537 | 1.18% |
| RA Capital Management | 9,770,773 | $52,762,174 | 1.07% |
| Deep Track Capital, LP | 3,952,000 | $21,340,800 | 0.90% |
| Cheyne Capital Management (UK) LLP | 55,829 | $301,477 | 0.53% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 295,115 | $1,593,621 | 0.46% |
| COMMODORE CAPITAL LP | 498,315 | $2,691 | 0.41% |
| Ikarian Capital, LLC | 254,945 | $1,376,703 | 0.33% |